FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

West-ward Pharmaceutical Fosphenytoin Sodium Injection Recall

Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single…

West-ward Pharmaceutical Corp. · Eatontown, NJ

Risk level
Class II
Reported by FDA
Aug 8, 2012
Recall ID
D-1438-2012
Check your lot numberHow we source this data

Summary

West-ward Pharmaceutical recalled Fosphenytoin Sodium Injection starting Apr 13, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1438-2012 on Aug 8, 2012. Reason: Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.

Product description

Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial, packaged in 10-count x 10 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9703-10), b) West-Ward (NDC 0143-9782-10).

Lot numbers, UPCs & expiration codes

Lot #s: a) 112161.1, 112162.1, 112163.1, Exp 05/13; b) 102165.2, 102167.1, Exp 05/12; 102190.1, 102191.1, 102191.2, 102192.1, 102213.1, Exp 07/12; 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1, Exp 09/12; 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1, Exp 11/12; 102342.1, 102343.1, 102344.1, 102345.1, Exp 12/12; 112019.1, 112020.1, 112021.1, 112022.1, 112023.1, Exp 01/13; 112156.1, 112157.1, 112158.1, 112159.1, 112160.1, Exp 05/13; 112164.1, Exp 06/13; 112203.1, 112204.1, 112205.1, 112206.1, Exp 07/13; 112262.1, 112263.1, Exp 09/13; 112301.1, 112302.1, 112303.1, 112304.1, Exp 10/13; 112323.1, 112324.1, 112325.1, Exp 11/13

Where it was sold

All lots were distributed throughout the US.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1438-2012
Classification
Class II
Status
Terminated
Recall initiated
Apr 13, 2012
FDA report date
Aug 8, 2012
Quantity
a) 74,960 vials; b) 911,070 vials
Recall type
Voluntary: Firm initiated
Recalling firm
West-ward Pharmaceutical Corp.

Original FDA data

Every field from FDA enforcement report D-1438-2012, exactly as published.

Show all FDA fields
City
Eatontown
State
NJ
Status
Terminated
Country
United States
Event ID
62627
Address
465 Industrial Way W
Code information
Lot #s: a) 112161.1, 112162.1, 112163.1, Exp 05/13; b) 102165.2, 102167.1, Exp 05/12; 102190.1, 102191.1, 102191.2, 102192.1, 102213.1, Exp 07/12; 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1, Exp 09/12; 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1, Exp 11/12; 102342.1, 102343.1, 102344.1, 102345.1, Exp 12/12; 112019.1, 112020.1, 112021.1, 112022.1, 112023.1, Exp 01/13; 112156.1, 112157.1, 112158.1, 112159.1, 112160.1, Exp 05/13; 112164.1, Exp 06/13; 112203.1, 112204.1, 112205.1, 112206.1, Exp 07/13; 112262.1, 112263.1, Exp 09/13; 112301.1, 112302.1, 112303.1, 112304.1, Exp 10/13; 112323.1, 112324.1, 112325.1, Exp 11/13
Postal code
07724-2209
Report date
Aug 8, 2012
Product type
Drugs
Recall number
D-1438-2012
Classification
Class II
Recalling firm
West-ward Pharmaceutical Corp.
Product quantity
a) 74,960 vials; b) 911,070 vials
Termination date
Jan 16, 2015
Reason for recall
Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial, packaged in 10-count x 10 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9703-10), b) West-Ward (NDC 0143-9782-10).
Distribution pattern
All lots were distributed throughout the US.
Recall initiation date
Apr 13, 2012
Initial firm notification
Letter
Center classification date
Aug 2, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1438-2012, published Aug 8, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls